HomeAI · summaries
Storia in 5 fonti
Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?
Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use” program.
Confronto fonti
5 prospettive sulla stessa storiaTimeline cronologica
- ·
newrepublic.com
Remember That Time Trump Said He “Probably Should” Take Ozempic?
A bombshell report about how a 79-year-old man got early access to a weight loss drug has all eyes on the president.
- ·
Eli Lilly Approved Obesity Drug for Mystery 79-Year-Old Patient
Questions are swirling over Donald Trump’s health after a bombshell report revealed a mystery man was getting unprecedented access to a weight-loss drug.
- ·
statnews.com
Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?
Exclusive: STAT has learned that Eli Lilly and the FDA allowed a 79-year-old to gain extraordinary access to an experimental obesity drug through the agency’s “compassionate use”…
- ·
Lilly's retatrutide has been offered to a single person via 'compassionate use' program
The "triple-G" weight loss drug, Pfizer's lung cancer trial results, and more biotech news from The Readout
- ·
arstechnica.com
Trump may be mystery patient in odd case of 79yo getting experimental obesity drug
Public notice of a single "compassionate use" case is odd in every way.
- ·
huffpost.com
It Kinda Looks Like Trump Might Be Taking An Experimental Obesity Drug?
Retatrutide has not been approved by the FDA, but precisely one 79-year-old man was granted access via "compassionate use."
- ·
gizmodo.com
Just Who Is the Mystery 79-Year-Old Patient Who Got Special Access to an Experimental Weight Loss Drug?
The White House has denied that the application was filed on behalf of President Donald Trump.
- ·
Democrats press White House on who got special access to Eli Lilly’s new obesity drug
The unusual access to an experimental drug has captured the attention of the American public as well.